Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (17140)	6/20/2005 12:08:06 AM
From: Biomaven	Read Replies (1) \| Respond to of 52153

There's no dispute that there are many chronic illness such as those you mention which are prevalent in African Americans, as well as several that are prevalent in Ashkenazi Jews (like Tay Sachs). Celiac disease (gluten intolerance) is most widespread in Northern Europeans. But the real controversy comes when you look at "standard" diseases like hypertension and heart failure and perhaps prostate cancer. For some reason there you get a visceral response when the suggestion is made that the very different prevalence, disease course and response to treatment may be the result of genetic differences corresponding to race rather than other factors. Here's a post I made about this last year related to two NEJM articles: Message 20323487 Peter